serotonin receptor agonists การใช้

• In addition, it acts as a non-selective serotonin receptor agonist.
• Eletriptan is a serotonin receptor agonist, specifically an agonist of certain 6 ] receptors.
• The third common mechanism which analeptics take advantage of is to act as serotonin receptor agonists.
• Many fungi synthesize the partial, non-selective, serotonin receptor agonist / analog psilocin.
• Several selective SDRAs are known however, though these compounds also act as non-selective serotonin receptor agonists.
• Many ?MT, also tryptamines, are SNDRAs and non-selective serotonin receptor agonists that were formerly used as antidepressants.
• Nonselective serotonin receptor agonist and serotonin releasing agent, is an active metabolite of trazodone and has been suggested to possibly play a role in its therapeutic benefits.
• The serotonin receptor agonist mCPP has a signi
  鹀ant affinity for 5-HT 2C receptors . mCPP patients experience multiple side effects due to non-selectivity over 5-HT 2A and 5-HT 2B receptors.
• Many ?-alkyltryptamines are drugs, acting as monoamine releasing agents, non-selective serotonin receptor agonists, and / or monoamine oxidase inhibitors, and produce psychostimulant, entactogen, and / or psychedelic effects.
• Piperazine derivatives such as trifluoromethylphenylpiperazine ( TFMPP ) have also been shown to exert a major part of their mechanism of action as nonselective serotonin receptor agonists, and MeOPP has also been demonstrated to act in this way.
• The mechanism that produces the hallucinogenic and entheogenic effects of isoproscaline is most likely to result from action as a serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines.
• It acts as a potent serotonin receptor agonist with similar affinity to the better-known compound 25B-NBOMe at 5-HT 2C receptors with pK i s values of 8.3 and 9.4, respectively.
• "' CP-94253 "'is a drug which acts as a potent and selective serotonin receptor agonist, with approximately 25x and 40x selectivity over the closely related 5-HT 1D and 5-HT 1A receptors.
• "' CP-93129 "'is a drug which acts as a potent and selective serotonin receptor agonist, with approximately 150x and 200x selectivity over the closely related 5-HT 1D and 5-HT 1A receptors.
• Dexfenfluramine is believed to be solely responsible for the appetite suppressant properties of fenfluramine, through a combination of indirect serotonin releasing agent and direct serotonin receptor agonist activities ( the latter of which are mediated fully by its active metabolite dexnorfenfluramine ).
• When selective activation of this receptor is desired in scientific research, the non-selective serotonin receptor agonist 5-Carboxamidotryptamine can be used in conjunction with selective antagonists for its other targets ( principally 5-HT 1A, 5-HT 1B, 5-HT 1D, and 5-HT 7 ).
• The mechanism that produces 2C-T-21 s hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
• The mechanism that produces 2C-T-8 s hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
• The mechanism that produces 2C-T-13's hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
• The mechanism of action that produces 2C-T-2 s hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.